TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 294 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,933,239 | -0.9% | 124,967 | +0.7% | 0.71% | +4.3% |
Q2 2023 | $1,949,862 | -4.0% | 124,116 | +0.7% | 0.68% | -7.1% |
Q1 2023 | $2,032,033 | -5.3% | 123,303 | -10.4% | 0.73% | -10.3% |
Q4 2022 | $2,145,796 | +21.0% | 137,551 | +0.6% | 0.82% | +5.4% |
Q3 2022 | $1,773,000 | – | 136,695 | – | 0.78% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Adelphi Capital LLP | 7,584,930 | $138,046,000 | 26.79% |
Glenview Capital Management | 15,260,512 | $277,741,000 | 6.37% |
Paulson & Co. | 11,295,846 | $205,584,000 | 5.34% |
GMT CAPITAL CORP | 2,871,395 | $52,259,000 | 3.72% |
MANAGED ASSET PORTFOLIOS, LLC | 966,643 | $17,593,000 | 3.09% |
TFG Asset Management GP Ltd | 1,443,052 | $26,264,000 | 1.76% |
Mondrian Investment Partners LTD | 3,274,660 | $58,944,000 | 1.46% |
Blackcrane Capital, LLC | 35,236 | $641,000 | 1.26% |
Lumbard & Kellner, LLC | 136,378 | $2,404,000 | 0.95% |
DAVIDSON INVESTMENT ADVISORS | 509,800 | $9,278,000 | 0.86% |